We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » House Extends Rare Pediatric Disease Priority Review Voucher Program
House Extends Rare Pediatric Disease Priority Review Voucher Program
The House of Representatives yesterday passed a bipartisan bill in a voice vote to extend the FDA’s rare pediatric drug priority review voucher program by four years.